Literature DB >> 9394753

How is Helicobacter pylori transmitted?

D R Cave1.   

Abstract

Helicobacter pylori is one of the world's most common pathogens. It colonizes about 60% of the world's population, causes gastritis and peptic ulcer, and is strongly associated with gastric adenocarcinoma and lymphoma. However, most individuals never develop clinical disease. Thirteen years after the culture of H. pylori by Marshall and Warren, we still do not know its major mode of transmission. Childhood represents the major period of acquisition of infection in the third world, but infection is rare in children in the developed world. Possible routes of infection include either oral-oral or fecal-oral, iatrogenic spread with inadvertent use of unsterile pH probes and endoscopes, and vectorial spread by flies. Evidence to support each route of transmission is provided, but there is no predominant route. The only significant reservoir of infection appears to be humans themselves. The organism has been found in some domestic cats and in nonhuman primates, but the opportunities for human interaction with the latter are rare, making infection from this source an unlikely possibility. The organism has the propensity to become a coccoid form. This may represent a persistent form in which H. pylori can exist in the environment, but it has yet to be shown that it can revert to the replicative form.

Entities:  

Mesh:

Year:  1997        PMID: 9394753     DOI: 10.1016/s0016-5085(97)80004-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  27 in total

Review 1.  Helicobacter pylori infection transmitted sexually via oral-genital contact: a hypothetical model.

Authors:  G D Eslick
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

Review 2.  The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.

Authors:  Artem Minalyan; Lilit Gabrielyan; David Scott; Jonathan Jacobs; Joseph R Pisegna
Journal:  Curr Gastroenterol Rep       Date:  2017-08

Review 3.  Pharmacokinetic considerations in the eradication of Helicobacter pylori.

Authors:  U Klotz
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

4.  Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA nephropathy.

Authors:  Kenichiro Kusano; Akira Inokuchi; Kazuma Fujimoto; Hiroshi Miyamoto; Osamu Tokunaga; Yuichiro Kuratomi; Rintaro Shimazu; Daisuke Mori; Fumio Yamasaki; Kazuki Kidera; Kyoko Tsunetomi; Junji Miyazaki
Journal:  J Gastroenterol       Date:  2009-12-08       Impact factor: 7.527

5.  The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall.

Authors:  K Costa; G Bacher; G Allmaier; M G Dominguez-Bello; L Engstrand; P Falk; M A de Pedro; F García-del Portillo
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

6.  Community-based familial study of Helicobacter pylori infection among healthy Japanese Brazilians.

Authors:  Lucy S Ito; Sueli M Oba-Shinjo; Samuel K Shinjo; Miyuki Uno; Suely K N Marie; Nobuyuki Hamajima
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

7.  Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori.

Authors:  Hung-Chuan Chiu; Tzu-Lung Lin; Jyh-Chin Yang; Jin-Town Wang
Journal:  BMC Microbiol       Date:  2009-07-13       Impact factor: 3.605

8.  Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils.

Authors:  T Ohkusa; I Okayasu; H Miwa; K Ohtaka; S Endo; N Sato
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Mireia Pedragosa; Salvador Vento; Raquel Hontecillas
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

10.  Helicobacter pylori infection in Ontario: prevalence and risk factors.

Authors:  Farah Naja; Nancy Kreiger; Terrence Sullivan
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.